Literature DB >> 25381201

Evidence for heightened hexokinase II immunoexpression in hepatocyte dysplasia and hepatocellular carcinoma.

Grace Guzman1, Rohini Chennuri, Alexander Chan, Bryan Rea, Ada Quintana, Roshan Patel, Pei-Zhang Xu, Hui Xie, Nissim Hay.   

Abstract

BACKGROUND: Normal hepatocytes exhibit low-affinity hexokinase (glucokinase [HKIV]), but during oncogenesis, there is a switch from HKIV to HKII expression. The aims of this study were to compare the immunoexpression of HKII in non-dysplastic cirrhosis (NDC), liver cell change/dysplasia in cirrhosis (LCD), HCC, and normal liver control tissues, and to correlate HKII expression with clinical and histopathological parameters.
DESIGN: Immunohistochemistry was performed on a liver cancer progression tissue array consisting of specimens from explants with cirrhosis, including 45 tissue samples with HCC, 108 without HCC, 143 with LCD, and 8 normal liver control tissues. HKII expression was quantified as positive pixel counts/square millimeter (ppc/mm(2)) by image analysis.
RESULTS: There was a stepwise increase in HKII level from normal liver tissue to NDC, to LCD, and to HCC (p = 0.001). HKII levels were significantly higher in areas of LCD versus NDC (p ≤ 0.001), and in LCD and HCC versus NDC (p = 0.007). HKII levels were similar in LCD and HCC (p = 0.124). HKII levels were higher in grade 2-4 versus grade 1 HCCs (p = 0.044), and in pleomorphic versus non-pleomorphic HCC variants (p = 0.041). Higher levels of HKII expression in LCD and HCC versus NDC and in higher tumor grade remained significant in multivariate analysis.
CONCLUSIONS: Higher levels of HKII immunoexpression in LDC and HCC compared with NDC suggest that upregulation of HKII occurs during the process of hepatocarcinogenesis in humans. In HCC, higher levels of HKII are associated with more aggressive histological features.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25381201      PMCID: PMC4323170          DOI: 10.1007/s10620-014-3364-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  52 in total

Review 1.  Tissue microarrays: a current medical research tool.

Authors:  Iqbal S Shergill; N K Shergill; M Arya; H R H Patel
Journal:  Curr Med Res Opin       Date:  2004-05       Impact factor: 2.580

2.  A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  Am J Clin Pathol       Date:  1981-05       Impact factor: 2.493

3.  Expression of hexokinase II and Glut-1 in untreated human breast cancer.

Authors:  Raya S Brown; Tonya M Goodman; Kenneth R Zasadny; Joel K Greenson; Richard L Wahl
Journal:  Nucl Med Biol       Date:  2002-05       Impact factor: 2.408

4.  Hypoxia induces hexokinase II gene expression in human lung cell line A549.

Authors:  S R Riddle; A Ahmad; S Ahmad; S S Deeb; M Malkki; B K Schneider; C B Allen; C W White
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-02       Impact factor: 5.464

Review 5.  Precursor lesions for liver cancer in humans.

Authors:  P P Anthony
Journal:  Cancer Res       Date:  1976-07       Impact factor: 12.701

6.  Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats.

Authors:  Chang An Chu; Yuka Fujimoto; Kayano Igawa; Joseph Grimsby; Joseph F Grippo; Mark A Magnuson; Alan D Cherrington; Masakazu Shiota
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-12-04       Impact factor: 4.052

7.  High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase.

Authors:  E Bustamante; P L Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

8.  Liver cell dysplasia: a premalignant condition.

Authors:  P P Anthony; C L Vogel; L F Barker
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

9.  Sterol regulatory element-binding protein-1 mediates the effect of insulin on hexokinase II gene expression in human muscle cells.

Authors:  Yvan Gosmain; Etienne Lefai; Stephan Ryser; Marina Roques; Hubert Vidal
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

10.  A morphometric study of liver cell dysplasia.

Authors:  M Roncalli; M Borzio; M V Tombesi; A Ferrari; E Servida
Journal:  Hum Pathol       Date:  1988-04       Impact factor: 3.466

View more
  16 in total

Review 1.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

2.  Profiling Carbohydrate Metabolism in Liver and Hepatocellular Carcinoma with [13C]-Glycerate Probes.

Authors:  Jun Chen; Evan LaGue; Junjie Li; Chendong Yang; Edward P Hackett; Manuel Mendoza; Jeffry R Alger; Ralph J DeBerardinis; Ian R Corbin; Kelvin L Billingsley; Jae Mo Park
Journal:  Anal Sens       Date:  2021-09-14

3.  Combinatorial CRISPR-Cas9 Metabolic Screens Reveal Critical Redox Control Points Dependent on the KEAP1-NRF2 Regulatory Axis.

Authors:  Dongxin Zhao; Mehmet G Badur; Jens Luebeck; Jose H Magaña; Amanda Birmingham; Roman Sasik; Christopher S Ahn; Trey Ideker; Christian M Metallo; Prashant Mali
Journal:  Mol Cell       Date:  2018-02-15       Impact factor: 17.970

4.  Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.

Authors:  Yulin Liu; Ke Wu; Liang Shi; Fan Xiang; Kaixiong Tao; Guobin Wang
Journal:  PLoS One       Date:  2016-11-08       Impact factor: 3.240

5.  Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.

Authors:  Dong Xu; Junzhe Jin; Hao Yu; Zheming Zhao; Dongyan Ma; Chundong Zhang; Honglei Jiang
Journal:  J Exp Clin Cancer Res       Date:  2017-03-20

6.  The catalytic inactivation of the N-half of human hexokinase 2 and structural and biochemical characterization of its mitochondrial conformation.

Authors:  Mir Hussain Nawaz; Juliana C Ferreira; Lyudmila Nedyalkova; Haizhong Zhu; César Carrasco-López; Serdal Kirmizialtin; Wael M Rabeh
Journal:  Biosci Rep       Date:  2018-02-21       Impact factor: 3.840

7.  Novel mitochondrion-targeting copper(II) complex induces HK2 malfunction and inhibits glycolysis via Drp1-mediating mitophagy in HCC.

Authors:  Mengmeng Li; Jiangjuan Shao; Zijian Guo; Chun Jin; Ling Wang; Feixia Wang; Yan Jia; Zhenzhu Zhu; Ziji Zhang; Feng Zhang; Shizhong Zheng; Xiaoyong Wang
Journal:  J Cell Mol Med       Date:  2020-01-28       Impact factor: 5.310

8.  Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection.

Authors:  Zhi-Feng Zhang; Xiao-Sha Feng; He Chen; Zhi-Jun Duan; Li-Xia Wang; Dong Yang; Pi-Xu Liu; Qiu-Ping Zhang; Yan-Ling Jin; Zhi-Gang Sun; Han Liu
Journal:  BMC Gastroenterol       Date:  2016-06-03       Impact factor: 3.067

9.  Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.

Authors:  Dannielle DeWaal; Veronique Nogueira; Alexander R Terry; Krushna C Patra; Sang-Min Jeon; Grace Guzman; Jennifer Au; Christopher P Long; Maciek R Antoniewicz; Nissim Hay
Journal:  Nat Commun       Date:  2018-01-31       Impact factor: 14.919

Review 10.  Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma.

Authors:  Jiang-Tao Zhong; Shui-Hong Zhou
Journal:  Oncotarget       Date:  2017-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.